Home / Nevirapine / Germany
DE ATC J05AG01 · updated 2 Nov 2026
Nevirapine shortage in Germany
Is there a Nevirapine shortage in Germany?
Yes. As of 2 Nov 2026, 2 Nevirapine products are reported short in Germany, the first since 17 Sep 2026. The company estimate for the return is 15 Apr 2027. Main reason: manufacturing problem.
Also short in Canada, France, Austria. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Nevirapin Mylan 400 mg Retardtabletten | Viatris Germany GmbH | 17 Sep 2026 | 15 Apr 2027 | Manufacturing problem Unzureichende Produktionskapazitäten |
| DE | Nevirapin Mylan 400 mg Retardtabletten | Viatris Germany GmbH | 17 Sep 2026 | 15 Apr 2027 | Manufacturing problem Unzureichende Produktionskapazitäten |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.